The Global Anticoagulants Market was valued at USD 28.8 Bn in 2020 and is expected to reach USD 41.89 Bn by 2027 growing at a CAGR of 7.8% during the forecast period (2021-2027).
In this era, a number of critical and serious diseases have shown increasing prevalence globally. One of the most prevalent disease is cardiovascular diseases (CVDs) which is caused due to the modern changes in the lifestyle globally. CVDs includes a group of disorder of heart and blood vessels that result in severe conditions like coronary heart disease, peripheral arterial disease, cerebrovascular disease, congenital heart disease, rheumatic heart disease, pulmonary embolism and deep vein thrombosis. Anticoagulant, commonly known as blood thinners are used in these diseases to help reduce/prevent the coagulation of blood, prolonging the blood clotting time. According to WHO, an estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke. Therefore, with the increasing cases of CVDs has resulted in increasing demand for more effective anticoagulants.
Rising number of surgical cases is another prominent factor driving the growth of anticoagulants. Surgery involves the risk of forming blood clots. This is because, the patient lies in the same position for a long-time during surgery, and for hours or days during his/her recovery period. As, lying in the same position leads to the formation of blood clots, the prevention of clots has become an essential part of perioperative surgical care. Therefore, increasing number of surgeries worldwide is leading to rise in the demand of Anticoagulants. For instance, the Center for Diseases Control and Prevention states that every year there are nearly 46.5 million procedures of surgeries performed in the U.S.
Furthermore, increasing aging population in several nations such as Japan, Singapore is also a key driver for the global anticoagulants market. Older adults are more likely to have conditions such as venous thromboembolism, atrial fibrillation, and knee and hip replacement surgeries and thus have a higher chance of developing blood clots, which in turn increases the risk of heart attacks and strokes. According to world bank, in 2020, an estimated 28.397% of the total population in Japan is older than 65, and is expected to rise to 40% by 2060. Thereby, blood thinners such as Xarelto is commonly prescribed to elders for treating and reducing the risk of blood clots.
The Global Anticoagulant Market Segmentation:
By Drug Class
By Route of Administration
By Distribution Channel
Based on drug class, The NOACs segment is the dominant segment in the anticoagulants market and is expected to show high growth rate in the coming years.
On the basis of drug class, the Global Anticoagulant Market is segmented as NOACs, Eliquis, Bevyxxa, Savaysa & Lixiana, Heparins & LMWH, Vitamin K Antagonists and other anticoagulant drugs. The NOACs segment is the dominant segment in the anticoagulants market and is expected to show high growth rate in the coming years. This is due to rising adoption of NOACs in the developing countries and increasing use of NOACs over warfarin. In addition, NOACs drugs, such as betrixaban, rivaroxaban, apixaban, dabigatran and edoxaban are used in the treatment and prevention of atrial fibrillation/myocardial infarction, pulmonary embolism, deep vein thrombosis (DVT). Moreover, NOACs provides several benefits over warfarin, such as no dietary restriction, rapid onset action, predictable pharmacokinetic action, lesser interaction with drugs and food, shorter half-life. These factors are driving the demand for NOAC’s in the global anticoagulants market.
Based on application, the pulmonary embolism (PE) is expected to witness a high growth rate during the forecast period.
On the basis of application, the Global Anticoagulant Market is segmented as Atrial Fibrillation & Heart Attack, Stroke, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE) and Others. Among these, the pulmonary embolism (PE) is expected to witness a high growth rate due to the rising cases of PE globally. Pulmonary Embolism is a life threating condition which sometimes subsequently lead to another serious condition such as deep vein thrombosis (DVT). Moreover, the rising prevalence of PE because of other contributing factors such as cancer, heart diseases and obesity are further expected to drive the growth of anticoagulant market as it helps in the formation of blood clots. However, the atrial fibrillation & heart attack segment is held a significant share in the anticoagulant market, owing to the rising use of anticoagulants in treatment of these conditions. According to the National Center for Biotechnology Information (NCBI), if untreated, acute PE is associated with a significant mortality rate accounting to 30% approximately. Owing to this, there is a high need for treatment of PE, which is further expected to increase the demand of anticoagulants.
Based on region, North America accounted for the largest share in the Global Anticoagulant Market
On the basis of region, Global Anticoagulant Market is segmented as North America, Latin America, Europe, Asia Pacific and Middle East & Africa. Among these, North America accounted for the largest share in 2020, owing to the rising awareness about therapeutic applications of anticoagulants in disease management and the growing obesity rate in the region. Moreover, the U.S. is found to have the highest obesity rate globally which is also positively driving the market in this region. According to Centers of Disease Control and Prevention (CDC), the US obesity prevalence was 42.4% in 2017 – 2018. From 1999–2018, US obesity rate increased from 30.5% to 42.4%. During the same time, the prevalence of severe obesity increased from 4.7% to 9.2%. Moreover, given the direct correlation between obesity and heart diseases, the demand of anticoagulants is high in the U.S., and is expected to witness a high growth rate during the forecast period.
Company Profiles and Competitive Intelligence
The key players operating in the Market are:
The report also provides in-depth analysis of Global Anticoagulant Market dynamics such as drivers and restraints.
The report also provides in-depth analysis of key trends in Global Anticoagulant Market
The report also provides in-depth analysis of recent news developments and investments.
The unique insight provided by this report also includes the following:
Ask for free product review call with the author
Share your specific research requirements for a customized report
Request for due diligence and consumer centric studies
Request for study updates, segment specific and country level reports